NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/09/2026
Back to search
Official data from USPTO
IT PHARMA INNOVATING TECHNOLOGY PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/09/2026
Trademark type
Combined
Nice classes
3, 5
Filing date
06/06/2022
Registration date
07/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
87
Owner location
ES
Examiner
PARKS, KIMBERLY L
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the designation "IT PHARMA INNOVATING TECHNOLOGY PHARMA" arranged on two lines. On the upper line "IT" with gray capital letters and "PHARMA" in red and lowercase letters, except for the first letter "P" which is capitalized. On the bottom line, "INNOVATING TECHNOLOGY PHARMA" with gray capital letters and in a smaller size.
Holders and representatives
Holders
INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
Representatives
Jesus Sanchelima, Esq. Sanchelima & Associates, P.A.
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics; non-medicinal toiletries; essential oils; non-medicinal hair lotions; cosmetic lotions for skin care; non-medicated essences for skin care; non-medicated preparations for skin care; beauty masks; body mask lotions for cosmetic use; skin care creams other than for medical use; tissues impregnated with cosmetic preparations; cosmetic preparations for slimming; cosmetic preparations for topical use; cosmetics for wrinkle treatment
Class 5
Sanitary preparations for medical use; medical productsliquid pharmaceutical treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; leaflet pharmaceutical treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; medicated cosmetic solutions in ampoules for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; medicated cosmetic solutions in vials for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; pharmaceutical preparations and substances for treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; sanitary preparations for medical purposesproducts thereofliquid treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; leaflet treatments for acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; antioxidant solution in spray being food supplements; chemical preparations for sanitary use; medicinal hair lotions; injectable pharmaceutical products for treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; injectable sanitary preparations products for medical use; medicinal creams for skin care; medicinal lotions for skin care; pharmacological pharmaceutical preparations for skin care; medical and pharmaceutical preparationsfor application by means of medical devicesfor treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; pharmaceutical products for treating or prevention of acnecellulitescarsskin agingstretch marksdark circlesdroopy eyelidssagging skinalopeciablood circulation problems; dietetic substances in the nature of liquid treatmentsleaflet treatmentsmedicated cosmetic solutions in ampoulesmedicated cosmetic solutions in vialsantioxidant solution in spray for medical use; dietetic foods for medical use; food for babies; dietetic supplements for humans.
Publications
History of USPTO decisions and trademark events.
39 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/29/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/27/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
01/27/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2024
GPNX
NOTIFICATION PROCESSED BY IB
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2024
PUBO
PUBLISHED FOR OPPOSITION
05/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/01/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/15/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/06/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/06/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/07/2023
GNFR
FINAL REFUSAL E-MAILED
12/07/2023
CNFR
FINAL REFUSAL WRITTEN
12/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
06/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/08/2023
CNRT
NON-FINAL ACTION WRITTEN
04/07/2023
DOCK
ASSIGNED TO EXAMINER
03/21/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/29/2022
Continuous trademark protection
Get notified about every new filing that threatens IT PHARMA INNOVATING TECHNOLOGY PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.